StockData
GSK plc logo

GSK plc

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$48.58−0.66 (-1.34%)

Close on Nov 18, 2026Market cap $104.82BP/E 13.2Yield –

GSK Venture & Equity Investment Commitments by Year

GSK Venture & Equity Investment Commitments: 175.00 £M in FY2025, down 13.8% from a year earlier.

Latest, FY2025
175.00
Period ended Dec 31, 2025
Change on a year earlier
-13.8%
203.00 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: GSK Form 20-F (FY2025, Inline XBRL) ↗

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedVenture & Equity Investment CommitmentsYear on yearSource
FY2025Dec 31, 2025175.00-13.8%GSK Form 20-F (FY2025, Inline XBRL) ↗
FY2024Dec 31, 2024203.00+32.7%GSK Form 20-F (FY2025, Inline XBRL) ↗
FY2023Dec 31, 2023153.00+10.9%GSK Form 20-F (FY2024, Inline XBRL) ↗
FY2022Dec 31, 2022138.00-5.5%GSK Form 20-F (FY2023, Inline XBRL) ↗
FY2021Dec 31, 2021146.00-4.6%GSK Form 20-F (FY2022, Inline XBRL) ↗
FY2020Dec 31, 2020153.00–GSK Form 20-F (FY2021, Inline XBRL) ↗

Cite this data

StockData. (2026). GSK Venture & Equity Investment Commitments, annual FY2020–FY2025 [Data set]. Compiled from GSK SEC filings and investor materials. https://stockdatahq.com/stocks/gsk/kpis/commit-investments

See every metric in the GSK KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?